Low Rates of Transition from Subcutaneous to Intravenous Formulation in Patients with Inflammatory Bowel Diseases Treated with Vedolizumab
AMERICAN JOURNAL OF GASTROENTEROLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
AMERICAN JOURNAL OF GASTROENTEROLOGY(2024)